Genetic classification helps with precise sirolimus treatment in slow-flow vascular malformations: A prospective cohort study - 17/07/25
, Xiaoxi Lin, MD, PhD a, ⁎ 
Key words : genomics, PIK3CA, sirolimus, targeted therapy, TEK, vascular malformation
| Drs Liu, Y. Chen, X. Chen, and Chang contributed equally in this article and should be considered as co-first authors. |
|
| Funding sources: This study was supported by the Clinical Research Program of Shanghai Municipal Health Commission (202040433), the Clinical Research Plan of Shanghai Hospital Development Center (SHDC2020CR2036B), Shanghai Municipal Key Clinical Specialty (shslczdzk00901), the Cross Research Fund Project of the Shanghai Ninth People's Hospital (JYJC202118), YBKA202209/Project of Biobank from Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, and General Program of National Natural Science Foundation of China (82472577). |
|
| Patient consent: Consent for the publication of recognizable patient photographs or other identifiable material was obtained by the authors and included at the time of article submission to the journal stating that all patients gave consent with the understanding that this information may be publicly available. |
|
| IRB approval status: Reviewed and approved by Shanghai Ninth People's Hospital IRB; approval SH9H-2019-T164-1 and SH9H-2020-TK385-1. |
Vol 93 - N° 2
P. 533-536 - agosto 2025 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
